Skip to content
Canadian orders above $200 ship free · Dispatched from Canadian stock

Buy KPV in Canada

KPV in Canada

KPV, offered as a lyophilised powder in 10 mg vials and in capsules. HPLC tests every batch, and shipping is from Canadian stock. For laboratory research use only.

Format
Capsules →
Size
$43.00$4.30/mg
Dispatched from Canadian stock

Buy more, pay less per vial

Add 2 more to save 4%

Frequently bought together

At a glance
Also known as
KPV peptide · Lys-Pro-Val · lysine-proline-valine · alpha-MSH (11-13) · α-MSH 11-13
Class
Melanocortin-derived tripeptide, the C-terminal fragment of α-MSH
Form
Lyophilised powder, in 10 mg vials and in capsules
Sizes
10 mg
Storage, dry
−20 °C, dry and dark
Storage, mixed
2–8 °C, use within 28 days of mixing (as generally reported for reconstituted peptides)
BAC water per size
10 mg: 2 mL
Molecular weight
342.4 g/mol

What is KPV?

KPV is a melanocortin-derived tripeptide (C-terminal fragment of α-MSH), and that classification is where the published work begins. The molecular weight is 342.4 g/mol. The recorded sequence is Lys-Pro-Val, residues 11–13 of α-MSH. The published research covers rat, mouse, cell culture and human skin ex vivo. No human study of KPV has been published, so nothing on this page describes what it does in a person. We keep it as a lyophilised powder in 10 mg vials and capsules; it is research material and nothing more. None of this is a medicine, and it is not for human or veterinary use.

What the research shows

StudyModelDose usedDurationFinding
Dalmasso G et al.2008 · Gastroenterology · PMID 18061177Mouse, DSS- and TNBS-induced colitis models; human intestinal epithelial cells (Caco2-BBE, HT29-Cl.19A) and T cells (Jurkat)Nanomolar concentrations in cells; in mice, KPV added to drinking water (amount not stated in the abstract)Not stated in the abstractNanomolar KPV inhibited NF-κB and MAP kinase signalling and reduced pro-inflammatory cytokine secretion, acting through the PepT1 transporter. Oral KPV reduced the incidence of DSS- and TNBS-induced colitis in mice.
Kannengiesser K et al.2008 · Inflamm Bowel Dis · PMID 18092346Mouse, DSS colitis and CD45RBhi transfer colitis models, including mice with a nonfunctional MC1 receptorNot stated in the abstractNot stated in the abstractKPV gave earlier recovery and stronger regain of body weight, with fewer inflammatory infiltrates and lower colonic MPO activity. In MC1R-deficient mice, KPV rescued all treated animals from death during DSS colitis, suggesting effects partly independent of MC1R.
Xiao B et al.2017 · Mol Ther · PMID 28143741Mouse, ulcerative colitis model; colonic epithelial cells and macrophagesOral KPV in hyaluronic acid-functionalised nanoparticles within a chitosan/alginate hydrogel; amount not stated in the abstractNot stated in the abstractThe HA-KPV nanoparticle hydrogel prevented mucosal damage and lowered TNF-α more than a KPV nanoparticle hydrogel without hyaluronic acid. The nanoparticles appeared nontoxic and biocompatible with intestinal cells.
Sun J et al.2021 · ACS Biomater Sci Eng · PMID 34547895Rat, TNBS-induced ulcerative colitis model (rectal hydrogel)KPV in a 4% SH-PGA hydrogel, given rectally; KPV amount not stated in the abstractNot stated in the abstractThe KPV hydrogel reduced body weight loss and disease activity score, prevented colon shortening, lowered colonic myeloperoxidase and reduced TNF-α and IL-6. The abstract notes that plain KPV solution is very unstable when given rectally.
Zhao Y et al.2022 · Acta Biomater · PMID 35245681Rat, TNBS-induced colitis model (intracolonic hydrogel)KPV captured in a PMSP hydrogel, given intracolonically; amount not stated in the abstractNot stated in the abstractThe hydrogel significantly improved the effect of KPV on colitis, the colon's epithelial barrier recovered, and gut flora shifted toward microorganisms associated with gut homeostasis.
Zhang L et al.2024 · Adv Healthc Mater · PMID 39252648Mouse, vascular calcification model; cells in vitro (KPV combined with rapamycin)KPV-rapamycin nanoparticles; amount not stated in the abstractNot stated in the abstractKPV-rapamycin nanoparticles significantly inhibited vascular calcification in mice compared with the other treatment groups, with reduced inflammatory responses and activated autophagy. The effect of KPV alone cannot be separated from rapamycin in this design.
Pawar K et al.2017 · J Pharm Sci · PMID 28343991Human skin ex vivo (dermatomed), transdermal delivery studyNot stated in the abstractNot stated in the abstractPassive KPV permeation was below detection (0.01 μg/mL). Microneedles raised it to 4.4 μg/cm²/h, and iontophoresis alone and with microneedles increased it 8- and 35-fold over microneedles alone.
Elliott RJ et al.2004 · J Invest Dermatol · PMID 15102092Cell culture (HaCaT and normal human keratinocytes; Chinese hamster ovary cells expressing MC1R)10⁻¹⁵ to 10⁻⁷ MNot stated in the abstractKPV did not raise cyclic AMP in keratinocytes. It raised intracellular calcium in HaCaT keratinocytes when an adenosine agonist was present, and in cells transfected with the MC1 receptor.

What these studies don't show: Every study above ran in animals or in culture. None of them shows what KPV does in a person, because that has never been tested. Differences between species make it unsafe to assume anything translates directly. A certificate of analysis tells you what the material is, not what it does.

Every study links to its PubMed record. See all KPV studies in the research library →

KPV price in Canada: 10mg vial

Buy KPV in Canada in a 10mg vial, plus capsules and a starter kit. Prices are in Canadian dollars, you pay by Interac e-Transfer or bank transfer, and orders are shipped from Canadian stock.

SizePricePer mg
10 mg$43.00$4.30/mg

Other formats and kits

Is KPV available in Canada?

No KPV product is authorized in Canada; no DIN has ever been issued for it. Health Canada has reached no finding on it, since it has never been submitted for one. Borealis Peptides carries it for in-vitro research and offers it for use in no living subject. How Health Canada treats research peptides →

Side effects reported in studies

A small study reporting no effect is not proof of safety. Every statement is pinned to the study that made it. Not one of the cited abstracts records a tolerability finding for KPV. Read more →

Doses used in studies

Read more →

KPV FAQ

What is KPV?

KPV is a melanocortin-derived tripeptide (C-terminal fragment of α-MSH). The published research covers rat, mouse, cell culture and human skin ex vivo. Borealis Peptides offers it as a lyophilised powder in 10 mg vials and capsules for in-vitro laboratory research. It is no medicine and is not for use in humans or animals. Each reference here appears alongside the model it ran in and the result as it was published.

Where can I buy KPV in Canada?

Borealis Peptides sends KPV out of Canadian stock to research and business addresses within Canada. It comes in 10 mg vials. HPLC tests every batch, and the certificate names the batch in your vial. Orders are taken for laboratory research only.

Is KPV legal in Canada?

No KPV product is authorized in Canada; no DIN has ever been issued for it. Health Canada has reached no finding on it, since it has never been submitted for one. Borealis Peptides keeps it for in-vitro work and supplies it for no use in a living subject. Health Canada has stated that "Research Use Only" labelling does not make a product legal to use in a person, so for us it describes what the material is supplied for and nothing beyond that.

How much KPV should I use?

We take no dosing questions. KPV is not supplied for use in a person or an animal, so there is no dose to set out. What this page carries is the amount each cited study used and the model it used it in, reproduced as the authors published it.

Has KPV been tested in people?

No. The 8 studies cited here used animals or cell culture. There is no published human study of KPV, so there is no evidence about what it does in a person, and this page makes no such claim. The animal work is listed with its model so it can be read for exactly what it is.

What storage does KPV need?

Keep sealed vials at −20 °C, dry and shielded from light. After reconstitution, 2–8 °C. The lyophilised powder withstands ambient temperature in transit, so it ships without ice and goes into the fridge on arrival. Light and repeated warming harm it more than the trip itself.

Does KPV need bacteriostatic water?

The capsules are a dry oral format and take no liquid at all. Only the lyophilised vial comes dry, and that is the single format bacteriostatic water is relevant to. It is sold separately. Testing runs batch by batch, so the certificate matches the vial rather than the product line.

How is the purity of KPV confirmed?

HPLC tests each batch before it is sold, and the certificate points to the batch in your vial rather than to the product at large. Filing that batch number with your records is what lets an observation be reproduced later. Certificates are available on request.

How does KPV compare with KLOW and BPC-157?

They are distinct compounds with distinct bodies of literature, and no ranking is given here. KLOW and BPC-157 have 8 cited studies and 7 cited studies on their page against 8 here. The comparison worth making is between the two study tables and the models that sit behind them.

Compare with